NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 894.50
+9.80 (1.11%)
Feb 18, 2026, 1:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 158.46 billion as of February 17, 2026. Its market cap has decreased by -24.45% in one year.
Market Cap
158.46B
Enterprise Value
129.07B
Revenue
45.63B
Ranking
n/a
PE Ratio
10.18
Stock Price
894.50
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 158.46B, an increase of 36,803.29%. That is a compound annual growth rate of 24.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 158.46B | -2.03% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 369.39B |
| Gland Pharma | 297.91B |
| Emcure Pharmaceuticals | 278.80B |
| Wockhardt | 226.87B |
| Piramal Pharma | 217.83B |
| Eris Lifesciences | 189.00B |
| Alembic Pharmaceuticals | 152.73B |
| Cohance Lifesciences | 118.12B |